Micron Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Micron Technologies's estimated annual revenue is currently $11.7M per year.
- Micron Technologies's estimated revenue per employee is $201,000
Employee Data
- Micron Technologies has 58 Employees.
- Micron Technologies grew their employee count by -13% last year.
Micron Technologies's People
Name | Title | Email/Phone |
---|
Micron Technologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $43.2M | 215 | 6% | N/A | N/A |
#2 | $81.8M | 407 | 10% | N/A | N/A |
#3 | $11.7M | 58 | 0% | N/A | N/A |
#4 | $1011.8M | 5034 | -9% | N/A | N/A |
#5 | $44.8M | 223 | 1% | N/A | N/A |
#6 | $13.1M | 65 | 5% | N/A | N/A |
#7 | $16.5M | 82 | 41% | N/A | N/A |
#8 | $17.3M | 86 | -5% | N/A | N/A |
#9 | $67.9M | 338 | 23% | N/A | N/A |
#10 | $14.9M | 74 | 7% | N/A | N/A |
What Is Micron Technologies?
Micron Technologies is a leading international provider of particle size reduction and analytical contract services. We deliver first-class pharmaceutical contract micronization, milling and analytical services combining quality, speed of response and know-how. Micron Technologies has more than 25 years experience handling pharmaceutical materials and is a leader in air jet milling micronization. We are capable of processing both R&D and commercial volumes alike and are equipped with state of the art systems to ensure total product containment and quality. Our company operates two distinctive, directly compatible cGMP facilities, strategically positioned to serve the global pharmaceutical community. Our facilities have successfully passed all required regulatory inspections (FDA, MHRA, PMDA, etc.), and our quality systems have been reviewed by more than 200 international pharmaceutical companies worldwide. Micron has an outstanding reputation for offering reliable technical support. We help to solve drug substance bioavailability challenges, improve drug content uniformity, as well as provide the specific particle size needed for many inhaled drugs. Along with this, we conduct material characterization and stability studies and stay abreast of all regulatory issues surrounding new product development
keywords:N/AN/A
Total Funding
58
Number of Employees
$11.7M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.6M | 58 | 4% | N/A |
#2 | $7.6M | 58 | 2% | N/A |
#3 | $12.7M | 59 | N/A | N/A |
#4 | $7.8M | 60 | 0% | N/A |
#5 | $12.1M | 61 | 42% | N/A |